Premature ventricular contraction prevention: Difference between revisions
Jump to navigation
Jump to search
Homa Najafi (talk | contribs) |
Homa Najafi (talk | contribs) |
||
| Line 27: | Line 27: | ||
| colspan="1" style="text-align:center; background:LightGreen"|[[ESC Guidelines Classification Scheme#Classification of Recommendations|Class I]] | | colspan="1" style="text-align:center; background:LightGreen"|[[ESC Guidelines Classification Scheme#Classification of Recommendations|Class I]] | ||
|- | |- | ||
| bgcolor="LightGreen"|<nowiki></nowiki>'''1.''' In patients with ischemic heart disease, who either survive SCA due to VT/VF or experience hemodynamically unstable VT ''([[ACC AHA Guidelines Classification Scheme#Level of Evidence|Level of Evidence: B-R]])''<ref>{{cite journal|title=A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias|journal=New England Journal of Medicine|volume=337|issue=22|year=1997|pages=1576–1584|issn=0028-4793|doi=10.1056/NEJM199711273372202}}</ref><ref name="ConnollyGent2000">{{cite journal|last1=Connolly|first1=Stuart J.|last2=Gent|first2=Michael|last3=Roberts|first3=Robin S.|last4=Dorian|first4=Paul|last5=Roy|first5=Denis|last6=Sheldon|first6=Robert S.|last7=Mitchell|first7=L. Brent|last8=Green|first8=Martin S.|last9=Klein|first9=George J.|last10=O’Brien|first10=Bernard|title=Canadian Implantable Defibrillator Study (CIDS)|journal=Circulation|volume=101|issue=11|year=2000|pages=1297–1302|issn=0009-7322|doi=10.1161/01.CIR.101.11.1297}}</ref><ref name="Connolly2000">{{cite journal|last1=Connolly|first1=S|title=Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials|journal=European Heart Journal|volume=21|issue=24|year=2000|pages=2071–2078|issn=0195668X|doi=10.1053/euhj.2000.2476}}</ref><ref name="KuckCappato2000">{{cite journal|last1=Kuck|first1=Karl-Heinz|last2=Cappato|first2=Riccardo|last3=Siebels|first3=Jürgen|last4=Rüppel|first4=Rudolf|title=Randomized Comparison of Antiarrhythmic Drug Therapy With Implantable Defibrillators in Patients Resuscitated From Cardiac Arrest|journal=Circulation|volume=102|issue=7|year=2000|pages=748–754|issn=0009-7322|doi=10.1161/01.CIR.102.7.748}}</ref> or stable sustained VT ''([[ACC AHA Guidelines Classification Scheme#Level of Evidence|Level of Evidence: B-NR]])'' not due to reversible causes, an ICD is recommended if meaningful survival greater than 1 year is expected. | | bgcolor="LightGreen"|<nowiki></nowiki>'''1.''' In patients with ischemic heart disease, who either survive SCA due to VT/VF or experience hemodynamically unstable VT ''([[ACC AHA Guidelines Classification Scheme#Level of Evidence|Level of Evidence: B-R]])''<ref>{{cite journal|title=A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias|journal=New England Journal of Medicine|volume=337|issue=22|year=1997|pages=1576–1584|issn=0028-4793|doi=10.1056/NEJM199711273372202}}</ref><ref name="ConnollyGent2000">{{cite journal|last1=Connolly|first1=Stuart J.|last2=Gent|first2=Michael|last3=Roberts|first3=Robin S.|last4=Dorian|first4=Paul|last5=Roy|first5=Denis|last6=Sheldon|first6=Robert S.|last7=Mitchell|first7=L. Brent|last8=Green|first8=Martin S.|last9=Klein|first9=George J.|last10=O’Brien|first10=Bernard|title=Canadian Implantable Defibrillator Study (CIDS)|journal=Circulation|volume=101|issue=11|year=2000|pages=1297–1302|issn=0009-7322|doi=10.1161/01.CIR.101.11.1297}}</ref><ref name="Connolly2000">{{cite journal|last1=Connolly|first1=S|title=Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials|journal=European Heart Journal|volume=21|issue=24|year=2000|pages=2071–2078|issn=0195668X|doi=10.1053/euhj.2000.2476}}</ref><ref name="KuckCappato2000">{{cite journal|last1=Kuck|first1=Karl-Heinz|last2=Cappato|first2=Riccardo|last3=Siebels|first3=Jürgen|last4=Rüppel|first4=Rudolf|title=Randomized Comparison of Antiarrhythmic Drug Therapy With Implantable Defibrillators in Patients Resuscitated From Cardiac Arrest|journal=Circulation|volume=102|issue=7|year=2000|pages=748–754|issn=0009-7322|doi=10.1161/01.CIR.102.7.748}}</ref> or stable sustained VT ''([[ACC AHA Guidelines Classification Scheme#Level of Evidence|Level of Evidence: B-NR]])''<ref name="RaittRenfroe2001">{{cite journal|last1=Raitt|first1=Merritt H.|last2=Renfroe|first2=Ellen Graham|last3=Epstein|first3=Andrew E.|last4=McAnulty|first4=John H.|last5=Mounsey|first5=Paul|last6=Steinberg|first6=Jonathan S.|last7=Lancaster|first7=Scott E.|last8=Jadonath|first8=Ram L.|last9=Hallstrom|first9=Alfred P.|title=“Stable” Ventricular Tachycardia Is Not a Benign Rhythm|journal=Circulation|volume=103|issue=2|year=2001|pages=244–252|issn=0009-7322|doi=10.1161/01.CIR.103.2.244}}</ref> not due to reversible causes, an ICD is recommended if meaningful survival greater than 1 year is expected. | ||
'''2.''' A transvenous ICD provides intermediate value in the secondary prevention of SCD particularly when the patient’s risk of death due to a VA is deemed high and the risk | '''2.''' A transvenous ICD provides intermediate value in the secondary prevention of SCD particularly when the patient’s risk of death due to a VA is deemed high and the risk | ||
Revision as of 22:27, 27 April 2020
|
Premature ventricular contraction Microchapters |
|
Differentiating Premature Ventricular Contraction from other Disorders |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Premature ventricular contraction prevention On the Web |
|
to Hospitals Treating Premature ventricular contraction prevention |
|
Risk calculators and risk factors for Premature ventricular contraction prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]
Overview
There are no established measures for the secondary prevention of [disease name].
OR
Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].
Secondary Prevention
There are no established measures for the secondary prevention of [disease name].
OR
Effective measures for the secondary prevention of [disease name] include:
- [Strategy 1]
- [Strategy 2]
- [Strategy 3]
Recommendations for Secondary Prevention of SCD in Patients With Ischemic Heart Disease
| Class I |
| 1. In patients with ischemic heart disease, who either survive SCA due to VT/VF or experience hemodynamically unstable VT (Level of Evidence: B-R)[1][2][3][4] or stable sustained VT (Level of Evidence: B-NR)[5] not due to reversible causes, an ICD is recommended if meaningful survival greater than 1 year is expected.
2. A transvenous ICD provides intermediate value in the secondary prevention of SCD particularly when the patient’s risk of death due to a VA is deemed high and the risk of nonarrhythmic death (either cardiac or noncardiac) is deemed low based on the patient’s burden of comorbidities and functional status (Level of Evidence: B-R). 3. In patients with ischemic heart disease and unexplained syncope who have inducible sustained monomorphic VT on electrophysiological study, an ICD is recommended if meaningful survival of greater than 1 year is expected (Level of Evidence: B-NR).
|
References
- ↑ "A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias". New England Journal of Medicine. 337 (22): 1576–1584. 1997. doi:10.1056/NEJM199711273372202. ISSN 0028-4793.
- ↑ Connolly, Stuart J.; Gent, Michael; Roberts, Robin S.; Dorian, Paul; Roy, Denis; Sheldon, Robert S.; Mitchell, L. Brent; Green, Martin S.; Klein, George J.; O’Brien, Bernard (2000). "Canadian Implantable Defibrillator Study (CIDS)". Circulation. 101 (11): 1297–1302. doi:10.1161/01.CIR.101.11.1297. ISSN 0009-7322.
- ↑ Connolly, S (2000). "Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials". European Heart Journal. 21 (24): 2071–2078. doi:10.1053/euhj.2000.2476. ISSN 0195-668X.
- ↑ Kuck, Karl-Heinz; Cappato, Riccardo; Siebels, Jürgen; Rüppel, Rudolf (2000). "Randomized Comparison of Antiarrhythmic Drug Therapy With Implantable Defibrillators in Patients Resuscitated From Cardiac Arrest". Circulation. 102 (7): 748–754. doi:10.1161/01.CIR.102.7.748. ISSN 0009-7322.
- ↑ Raitt, Merritt H.; Renfroe, Ellen Graham; Epstein, Andrew E.; McAnulty, John H.; Mounsey, Paul; Steinberg, Jonathan S.; Lancaster, Scott E.; Jadonath, Ram L.; Hallstrom, Alfred P. (2001). ""Stable" Ventricular Tachycardia Is Not a Benign Rhythm". Circulation. 103 (2): 244–252. doi:10.1161/01.CIR.103.2.244. ISSN 0009-7322.